These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28424235)

  • 1. Increased alloimmunisation and transfusion reaction reporting in patients with solid-phase panreactivity.
    Olofson AM; Chandler RM; Marx-Wood CR; Babcock CA; Dunbar NM
    J Clin Pathol; 2017 Nov; 70(11):981-983. PubMed ID: 28424235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red cell alloimmunisation in oncology patients: A study from eastern India.
    Dhar S; Basu S
    Transfus Apher Sci; 2015 Jun; 52(3):345-9. PubMed ID: 25818996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence.
    Stack G; Tormey CA
    Transfusion; 2016 Nov; 56(11):2662-2667. PubMed ID: 27394029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-related red blood cell alloantibodies: induction and consequences.
    Tormey CA; Hendrickson JE
    Blood; 2019 Apr; 133(17):1821-1830. PubMed ID: 30808636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenging the dogma: Red blood cell-directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion.
    Oud JA; de Haas M; de Vooght KMK; van de Kerkhof D; Som N; Péquériaux NCV; Hudig F; van der Bom JG; Evers D; Zwaginga JJ
    Br J Haematol; 2024 May; 204(5):2103-2111. PubMed ID: 38494337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan.
    Chao YH; Wu KH; Lu JJ; Shih MC; Peng CT; Chang CW
    Blood Transfus; 2013 Jan; 11(1):71-4. PubMed ID: 22790261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
    Nickel RS; Hendrickson JE; Fasano RM; Meyer EK; Winkler AM; Yee MM; Lane PA; Jones YA; Pashankar FD; New T; Josephson CD; Stowell SR
    Transfusion; 2016 Jan; 56(1):107-14. PubMed ID: 26509333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of an automated solid-phase red cell adherence system compared with that of a manual gel microcolumn assay for the identification of antibodies eluted from red blood cells.
    Finck RH; Davis RJ; Teng S; Goldfinger D; Ziman AF; Lu Q; Yuan S
    Immunohematology; 2011; 27(1):1-5. PubMed ID: 22356479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody identification using both automated solid-phase red cell adherence assay and a tube polyethylene glycol antiglobulin method.
    Yamada C; Serrano-Rahman L; Vasovic LV; Mohandas K; Uehlinger J
    Transfusion; 2008 Aug; 48(8):1693-8. PubMed ID: 18482178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mi
    Yang CA; Lin JA; Chang CW; Wu KH; Yeh SP; Ho CM; Chang JG
    Transfus Med; 2016 Oct; 26(5):349-354. PubMed ID: 27634577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.
    Evers D; Middelburg RA; de Haas M; Zalpuri S; de Vooght KM; van de Kerkhof D; Visser O; Péquériaux NC; Hudig F; Schonewille H; Zwaginga JJ; van der Bom JG
    Lancet Haematol; 2016 Jun; 3(6):e284-92. PubMed ID: 27264038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of red blood cell alloantibody detection duration: analysis of multiply alloimmunized patients supports peritransfusion factors.
    Noiret L; Slater A; Higgins JM
    Transfusion; 2017 Aug; 57(8):1930-1937. PubMed ID: 28639314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell alloimmunisation in paroxysmal nocturnal hemoglobinuria.
    Basu S; Tahlan A; Kaur G; Kaur R; Garg S; Cruz SD
    J Assoc Physicians India; 2011 Feb; 59():128. PubMed ID: 21751657
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute haemolysis, DIC and renal failure after transfusion of uncross-matched blood during trauma resuscitation: illustrative case and literature review.
    Fiorellino J; Elahie AL; Warkentin TE
    Transfus Med; 2018 Aug; 28(4):319-325. PubMed ID: 29460456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and specificity of RBC alloantibodies in the general hospitalised population in Guangxi.
    Mo Z; Li H; Huang L; Jiao W
    Transfus Med; 2015 Oct; 25(5):313-9. PubMed ID: 26135712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matching.
    Schonewille H; van Zijl AM; Wijermans PW
    Transfusion; 2003 Jul; 43(7):939-44. PubMed ID: 12823754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Algorithm to Manage Inconclusive RBC Antibodies by Reflex Manual Testing.
    O'Brien JJ; Cooke RK; Ebrahim-Nejad AA; Hunt JM; Fontaine MJ
    Am J Clin Pathol; 2017 Dec; 149(1):29-34. PubMed ID: 29272886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Monocyte Monolayer Assay: Past, Present and Future.
    Tong TN; Cen S; Branch DR
    Transfus Med Rev; 2019 Jan; 33(1):24-28. PubMed ID: 30139679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.